Addiction Prevention and Responsible Opioid Practices Act

Summary

Addiction Prevention and Responsible Opioid Practices Act This bill establishes a series of requirements relating to opioid regulation, prescribing, and monitoring, including licensure requirements for pharmaceutical representatives, a national opioid drug mapping tool to monitor prescribing practices of Medicaid providers, and an excise tax on opioid manufacturers.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 17 May 2018

   Introduced

   Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

   Source: IntroReferral

2. 17 May 2018

   Introduced

   Introduced in House

   Source: IntroReferral

3. 17 May 2018

   Introduced

   Introduced in House

   Source: IntroReferral

4. 4 June 2018

   Referred

   Referred to the Subcommittee on Health.

   Source: Committee

5. 24 July 2018

   Referred

   Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 17 May 2018 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 17 May 2018

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 17 May 2018

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 17 May 2018

  Open at official source

Sponsors

• Matt Cartwright · D · Sponsor
• · hsju00 · Standing
• · hswm00 · Standing
• · hsed00 · Standing
• · hsif00 · Standing

Related records

• related to → Addiction Prevention and Responsible Opioid Practices Act